Data is more than just a hot topic; everyone is focusing on how they can better gather, handle and manipulate […]
Recently, we have been posting about the changes in user perceptions on the way genetic data is owned, handled, and […]
Many pharmaceutical companies are switching their focus to collecting, analysing and learning from large data sets. In fact, in early […]
With the cost of developing a drug doubling every 9 years, the pharma business model will soon become largely unsustainable. […]
As genomic sequencing becomes more routine, handling the sheer volume of data being produced is causing major issues. We must […]
Sano Genetics, Zetta Genomics and Genomics England have partnered to develop a novel system to allow rare disease patients and […]
Ask Jeeves may be a thing of the past as there’s a new butler in town. Specifically, one to serve […]
FLG: Can you introduce yourself and your work? I am currently a Health Informatics Director at AstraZeneca. I started my […]
Advancements in sequencing technology and per sample cost reductions are driving rapid adoption of NGS by labs all over the […]
Jo Balfour, one of the founding members and current Operations Manager at Cambridge Rare Disease Network (CRDN), has collaborated with […]
